Trial Profile
Comparative study of DR-3355 injection and pazufloxacin injection in patients with urinary tract infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary)
- Indications Cystitis; Pyelonephritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 07 Jun 2016 New trial record